GSTM3 and prostate carcinoma: It has been demonstrated that GSTM3 is associated with cancer risk at a genetic level, where the association of certain polymorphisms and/or mutations increases the risk of different types of cancer, such as lung cancer [23], prostate cancer [21], and colorectal cancer [17, 24].